Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
INDV
$39.01
+2.07%
INDV · Indivior Pharmaceuticals, Inc.
$39.01
+0.79 (+2.07%)
At close · Aug 14
Market Cap
$4.60B
Shares
118.01M
All earnings calls
Earnings call · FY2026 Q2
Q2 2026 Results and Webcast
Q2 2026 Results and Webcast
Forward guidance
2 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$343.00M
+13.6% YoY
Diluted EPS
$0.98
+600% YoY
Gross margin
85.7%
+2.9 pp YoY
Net income
$122.00M
+577.8% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 3, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Non-GAAP Operating Expenses
Full-year 2026
|
$430M – $450M | Non-GAAP | |
|
Adjusted EBITDA
Full-year 2026
|
$700M – $740M | Non-GAAP |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 3, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 3, 2026 · complete as-filed document